S&P・Nasdaq 本質的価値 お問い合わせ

ReShape Lifesciences Inc. RSLS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
34/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ReShape Lifesciences Inc. (RSLS) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Schneid Yair 2,461,000 株保有. その他の主要保有者には ARMISTICE CAPITAL, LLC および YOUNGSTROM SCOTT P.

RSLS インサイダー保有状況

最大保有者
Schneid Yair
2,461,000 株
買い(12ヶ月)
0
$0.00 評価額
売り(12ヶ月)
0
$0.00 評価額
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Schneid Yair 10 Percent Owner 2,461,000 2024-01-16
100%
2 Armistice Capital, Llc 10 Percent Owner 1,897,666 2021-06-22
77%
3 Youngstrom Scott P CFO and SVP, Finance 1,161,797 2018-04-20
47%
4 Bandy Barton P. President and CEO 773,098 2022-08-11
31%
5 Gladney Dan W Director 483,922 2021-09-17
20%
6 Huang Kelly Pres & Chief Executive Officer 300,000 2019-01-04
12%
7 Blackford Gary Director 253,429 2021-09-17
10%
8 Mcdougal Lori Courtney Director 253,429 2021-09-17
10%
9 Minocherhomjee Arda Phd Director 253,429 2021-09-17
10%
10 Domain Parters Vii L P 10 Percent Owner 187,500 2019-08-08
8%
11 Brister Mark Chief Technology Officer 110,281 2020-01-28
4%
12 Macdonald Robert J Chief Retail Officer 88,225 2020-01-28
4%
13 Vandenberg Amy Chief Clinical & Reg Officer 88,225 2020-01-28
4%
14 Moatazedi David Director 83,619 2019-07-25
3%
15 Shacknai Jonah Director 81,774 2018-06-14
3%
16 Schmidt Daina Vice President of Marketing 60,000 2018-10-16
2%
17 Rasdal Andrew P President, CEO & Exec Chairman 52,865 2020-06-25
2%
18 Hussainy Nooshin Chief Financial Officer 52,865 2020-06-25
2%
19 Norwood Matthew VP of Sales 50,000 2018-01-04
2%
20 Metzner Lisa VP of Marketing 40,000 2016-11-14
2%

RSLS の保有データがありません。

お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る